# TMS for Cognitive Decline in Aging and Preclinical AD

> **NCT06956300** · NA · RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Prodromal Alzheimer's Disease
- Preclinical Alzheimer's Disease
- Healthy Aging
- Cognitive Decline

## Interventions

- **DEVICE:** Active rTMS
- **DEVICE:** Sham rTMS

## Key facts

- **NCT ID:** NCT06956300
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-07
- **Primary completion:** 2029-08-31
- **Final completion:** 2029-08-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06956300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06956300, "TMS for Cognitive Decline in Aging and Preclinical AD". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT06956300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*